These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 15522624)

  • 1. Evolution of isotype switching.
    Stavnezer J; Amemiya CT
    Semin Immunol; 2004 Aug; 16(4):257-75. PubMed ID: 15522624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolution of class switch recombination function in fish activation-induced cytidine deaminase, AID.
    Wakae K; Magor BG; Saunders H; Nagaoka H; Kawamura A; Kinoshita K; Honjo T; Muramatsu M
    Int Immunol; 2006 Jan; 18(1):41-7. PubMed ID: 16291656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA targets of AID evolutionary link between antibody somatic hypermutation and class switch recombination.
    Hackney JA; Misaghi S; Senger K; Garris C; Sun Y; Lorenzo MN; Zarrin AA
    Adv Immunol; 2009; 101():163-89. PubMed ID: 19231595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation-induced cytidine deaminase: a dual role in class-switch recombination and somatic hypermutation.
    Durandy A
    Eur J Immunol; 2003 Aug; 33(8):2069-73. PubMed ID: 12884279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathophysiology of B-cell intrinsic immunoglobulin class switch recombination deficiencies.
    Durandy A; Taubenheim N; Peron S; Fischer A
    Adv Immunol; 2007; 94():275-306. PubMed ID: 17560278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Separate domains of AID are required for somatic hypermutation and class-switch recombination.
    Shinkura R; Ito S; Begum NA; Nagaoka H; Muramatsu M; Kinoshita K; Sakakibara Y; Hijikata H; Honjo T
    Nat Immunol; 2004 Jul; 5(7):707-12. PubMed ID: 15195091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation-induced deaminase: light and dark sides.
    de Yébenes VG; Ramiro AR
    Trends Mol Med; 2006 Sep; 12(9):432-9. PubMed ID: 16861038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Negative regulation of activation-induced cytidine deaminase in B cells.
    Muto T; Okazaki IM; Yamada S; Tanaka Y; Kinoshita K; Muramatsu M; Nagaoka H; Honjo T
    Proc Natl Acad Sci U S A; 2006 Feb; 103(8):2752-7. PubMed ID: 16477013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism and control of V(D)J recombination versus class switch recombination: similarities and differences.
    Dudley DD; Chaudhuri J; Bassing CH; Alt FW
    Adv Immunol; 2005; 86():43-112. PubMed ID: 15705419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AID targeting in antibody diversity.
    Pavri R; Nussenzweig MC
    Adv Immunol; 2011; 110():1-26. PubMed ID: 21762814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of the activation-induced cytidine deaminase gene from zebrafish: an evolutionary analysis.
    Zhao Y; Pan-Hammarström Q; Zhao Z; Hammarström L
    Dev Comp Immunol; 2005; 29(1):61-71. PubMed ID: 15325524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AID-initiated purposeful mutations in immunoglobulin genes.
    Goodman MF; Scharff MD; Romesberg FE
    Adv Immunol; 2007; 94():127-55. PubMed ID: 17560274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of activation-induced cytidine deaminase is regulated by cell division, providing a mechanistic basis for division-linked class switch recombination.
    Rush JS; Liu M; Odegard VH; Unniraman S; Schatz DG
    Proc Natl Acad Sci U S A; 2005 Sep; 102(37):13242-7. PubMed ID: 16141332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation-induced cytidine deaminase: structure-function relationship as based on the study of mutants.
    Durandy A; Peron S; Taubenheim N; Fischer A
    Hum Mutat; 2006 Dec; 27(12):1185-91. PubMed ID: 16964591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-strand DNA breaks in Ig class switch recombination that depend on UNG but not AID.
    Arudchandran A; Bernstein RM; Max EE
    Int Immunol; 2008 Nov; 20(11):1381-93. PubMed ID: 18794203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of class switch recombination and somatic hypermutation in patients affected with autosomal dominant hyper-IgM syndrome type 2.
    Imai K; Zhu Y; Revy P; Morio T; Mizutani S; Fischer A; Nonoyama S; Durandy A
    Clin Immunol; 2005 Jun; 115(3):277-85. PubMed ID: 15893695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AID in somatic hypermutation and class switch recombination.
    Longerich S; Basu U; Alt F; Storb U
    Curr Opin Immunol; 2006 Apr; 18(2):164-74. PubMed ID: 16464563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Target sequence accessibility limits activation-induced cytidine deaminase activity in primary mediastinal B-cell lymphoma.
    Popov SW; Moldenhauer G; Wotschke B; Brüderlein S; Barth TF; Dorsch K; Ritz O; Möller P; Leithäuser F
    Cancer Res; 2007 Jul; 67(14):6555-64. PubMed ID: 17638864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncogenic events triggered by AID, the adverse effect of antibody diversification.
    Pérez-Durán P; de Yebenes VG; Ramiro AR
    Carcinogenesis; 2007 Dec; 28(12):2427-33. PubMed ID: 17804422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of antigen receptor evolution.
    Eason DD; Cannon JP; Haire RN; Rast JP; Ostrov DA; Litman GW
    Semin Immunol; 2004 Aug; 16(4):215-26. PubMed ID: 15522620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.